Shopping Cart
Remove All
Your shopping cart is currently empty
CE-355621
Catalog No. T9901A-1782 Copy Product Info
🥰Excellent
CE-355621 is a humanized anti-c-Met IgG1 monoclonal antibody. It effectively binds to human c-Met in A549 cells (KD= 200 pM, IC50= 466 pM) and also binds effectively to c-Met in cynomolgus monkey kidney cells (KD= 610 pM). CE-355621 inhibits the c-Met signaling pathway by blocking HGF binding and significantly suppresses tumor growth dependent on the c-Met/HGF pathway. It is applicable for research in cancers such as glioblastoma and gastric cancer.
CE-355621
Copy Product Info🥰Excellent
Catalog No. T9901A-1782
CE-355621 is a humanized anti-c-Met IgG1 monoclonal antibody. It effectively binds to human c-Met in A549 cells (KD= 200 pM, IC50= 466 pM) and also binds effectively to c-Met in cynomolgus monkey kidney cells (KD= 610 pM). CE-355621 inhibits the c-Met signaling pathway by blocking HGF binding and significantly suppresses tumor growth dependent on the c-Met/HGF pathway. It is applicable for research in cancers such as glioblastoma and gastric cancer.
CE-355621
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | CE-355621 is a humanized anti-c-Met IgG1 monoclonal antibody. It effectively binds to human c-Met in A549 cells (KD= 200 pM, IC50= 466 pM) and also binds effectively to c-Met in cynomolgus monkey kidney cells (KD= 610 pM). CE-355621 inhibits the c-Met signaling pathway by blocking HGF binding and significantly suppresses tumor growth dependent on the c-Met/HGF pathway. It is applicable for research in cancers such as glioblastoma and gastric cancer. |
| In vitro | CE-355621 is effective in blocking the binding of c-Met with HGF and induces c-Met degradation in A549 cells at concentrations ranging from 0.01 to 100 nM over 4 hours. At concentrations of 0.01 nM to 10 nM for 24 hours, CE-355621 significantly inhibits c-Met activation in U87MG cells. Additionally, it induces c-Met degradation in U87MG cells at concentrations of 0.01 to 10 μg/mL over a 48-hour period. |
| In vivo | Administered intraperitoneally, CE-355621 at doses ranging from 25-200 μg on days 0, 2, 3, 6, and 8 significantly delayed tumor growth in U87MG xenografts in female CD-1 nu/nu mice. Additionally, a dose of 400 μg on days 7 and 14 markedly inhibited tumor growth of GTL-16 xenografts in the same mouse model. A single dose of 200 μg on day 7 effectively reduced tumor volume growth and [18 F-FDG] uptake in U87MG xenografts in female nude mice (nu/nu). |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy CE-355621 | purchase CE-355621 | CE-355621 cost | order CE-355621 | CE-355621 in vivo | CE-355621 in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.